The 1 analysts offering 12-month price forecasts for Utah Medical Products Inc have a median target of 65.23, with a high estimate of 65.23 and a low estimate of 65.23. The median estimate represents a -25.54% decrease from the last price of 87.60.
The current consensus among 1 polled investment analysts is to Buy stock in Utah Medical Products Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share --
Reporting Date TBD
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.